Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael C Levin

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
International Journal of MS Care|June 14, 2019
Stabilization Without Rituximab After Disease Activation in an Alemtuzumab-Treated Patient with Multiple Sclerosis and a Literature OverviewChantal Kahovec, Michael C Levin
The Journal of Clinical Psychiatry|January 1, 2015
Developing a therapeutic plan for treating MS: evidence for new treatmentsMichael C Levin, W Clay Jackson
Frontiers in Pharmacology|December 5, 2015
Importance of Apolipoprotein A-I in Multiple SclerosisLidia A Gardner, Michael C Levin
Neurology International|July 2, 2021
Diagnostic Dilemma: An Atypical Case of Astrocytoma in a Patient with Relapsing-Remitting Multiple SclerosisChantal Kahovec, Aman Saini, Michael C Levin
Plos One|February 16, 2019
Localization of near-infrared labeled antibodies to the central nervous system in experimental autoimmune encephalomyelitisSangmin Lee, Hannah E Salapa, Michael C Levin
Annals of Neurology|June 2, 2005
Autoimmunity to heterogeneous nuclear ribonucleoproteins in neurological diseaseMichael C Levin, Sang Min Lee, Yvette Morcos
International Journal of MS Care|May 16, 2020
The Dilemma of When to Stop Disease-Modifying Therapy in Multiple Sclerosis: A Narrative Review and Canadian Regional Reimbursement PoliciesKatherine B Knox, Aman Saini, Michael C Levin
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
A role for hypertrophic astrocytes and astrocyte precursors in a case of rapidly progressive multiple sclerosisYvette Morcos, Sang Min Lee, Michael C Levin
International Journal of Molecular Sciences|July 2, 2020
The Potential Contribution of Dysfunctional RNA-Binding Proteins to the Pathogenesis of Neurodegeneration in Multiple Sclerosis and Relevant ModelsCole D Libner, Hannah E Salapa, Michael C Levin
Journal of Neuroscience Research|November 23, 2019
Dysfunctional RNA-binding protein biology and neurodegeneration in experimental autoimmune encephalomyelitis in female miceHannah E Salapa, Cole D Libner, Michael C Levin
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
International Journal of MS Care|June 14, 2019
Stabilization Without Rituximab After Disease Activation in an Alemtuzumab-Treated Patient with Multiple Sclerosis and a Literature OverviewChantal Kahovec, Michael C Levin
The Journal of Clinical Psychiatry|January 1, 2015
Developing a therapeutic plan for treating MS: evidence for new treatmentsMichael C Levin, W Clay Jackson
Frontiers in Pharmacology|December 5, 2015
Importance of Apolipoprotein A-I in Multiple SclerosisLidia A Gardner, Michael C Levin
Neurology International|July 2, 2021
Diagnostic Dilemma: An Atypical Case of Astrocytoma in a Patient with Relapsing-Remitting Multiple SclerosisChantal Kahovec, Aman Saini, Michael C Levin
Plos One|February 16, 2019
Localization of near-infrared labeled antibodies to the central nervous system in experimental autoimmune encephalomyelitisSangmin Lee, Hannah E Salapa, Michael C Levin
Annals of Neurology|June 2, 2005
Autoimmunity to heterogeneous nuclear ribonucleoproteins in neurological diseaseMichael C Levin, Sang Min Lee, Yvette Morcos
International Journal of MS Care|May 16, 2020
The Dilemma of When to Stop Disease-Modifying Therapy in Multiple Sclerosis: A Narrative Review and Canadian Regional Reimbursement PoliciesKatherine B Knox, Aman Saini, Michael C Levin
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 21, 2003
A role for hypertrophic astrocytes and astrocyte precursors in a case of rapidly progressive multiple sclerosisYvette Morcos, Sang Min Lee, Michael C Levin
International Journal of Molecular Sciences|July 2, 2020
The Potential Contribution of Dysfunctional RNA-Binding Proteins to the Pathogenesis of Neurodegeneration in Multiple Sclerosis and Relevant ModelsCole D Libner, Hannah E Salapa, Michael C Levin
Journal of Neuroscience Research|November 23, 2019
Dysfunctional RNA-binding protein biology and neurodegeneration in experimental autoimmune encephalomyelitis in female miceHannah E Salapa, Cole D Libner, Michael C Levin
Pageof 7